Adient (NYSE:ADNT) Stock Rating Upgraded by Wall Street Zen

Adient (NYSE:ADNT) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Friday.

Several other brokerages also recently weighed in on ADNT. JPMorgan Chase & Co. cut their price target on Adient from $26.00 to $24.00 and set a “neutral” rating on the stock in a research report on Thursday, November 6th. UBS Group set a $30.00 target price on Adient and gave the stock a “buy” rating in a report on Wednesday, January 14th. Morgan Stanley raised Adient from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $17.00 to $20.00 in a report on Monday, December 8th. Citigroup lowered their price objective on Adient from $25.00 to $22.50 and set a “neutral” rating on the stock in a research report on Wednesday, November 12th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Adient in a report on Wednesday. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $24.56.

Adient Price Performance

Shares of NYSE ADNT opened at $21.59 on Friday. Adient has a 52 week low of $10.04 and a 52 week high of $26.16. The business’s 50 day moving average price is $19.77 and its 200 day moving average price is $22.05. The company has a quick ratio of 0.93, a current ratio of 1.12 and a debt-to-equity ratio of 1.16. The firm has a market cap of $1.69 billion, a P/E ratio of -6.47, a P/E/G ratio of 0.71 and a beta of 1.61.

Adient (NYSE:ADNT) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.52 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.03). The business had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.58 billion. Adient had a negative net margin of 1.93% and a positive return on equity of 7.81%. The business’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.68 earnings per share. On average, sell-side analysts expect that Adient will post 1.76 earnings per share for the current year.

Insiders Place Their Bets

In other Adient news, EVP Michel Pierre Rose Berthelin sold 2,500 shares of the stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $19.71, for a total transaction of $49,275.00. Following the transaction, the executive vice president directly owned 116,425 shares of the company’s stock, valued at $2,294,736.75. This trade represents a 2.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.72% of the company’s stock.

Institutional Trading of Adient

Institutional investors and hedge funds have recently modified their holdings of the stock. Letko Brosseau & Associates Inc. acquired a new position in shares of Adient during the 2nd quarter worth about $28,839,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of Adient by 439.3% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,171,695 shares of the company’s stock valued at $22,801,000 after acquiring an additional 954,441 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Adient by 921.9% in the third quarter. Assenagon Asset Management S.A. now owns 812,329 shares of the company’s stock valued at $19,561,000 after acquiring an additional 732,837 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Adient by 5,271.0% in the fourth quarter. SG Americas Securities LLC now owns 419,531 shares of the company’s stock worth $8,042,000 after acquiring an additional 411,720 shares during the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of Adient by 143.3% in the second quarter. AQR Capital Management LLC now owns 581,242 shares of the company’s stock worth $11,276,000 after acquiring an additional 342,329 shares during the last quarter. Hedge funds and other institutional investors own 92.44% of the company’s stock.

About Adient

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.